$284 Million is the total value of Flagship Pioneering Inc.'s 5 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 42.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MCRB | SERES THERAPEUTICS INC | $143,316,000 | +0.3% | 12,682,876 | 0.0% | 50.54% | +33.0% | |
| SYRS | SYROS PHARMACEUTICALS INC | $77,339,000 | +1.0% | 4,806,656 | 0.0% | 27.27% | +34.0% | |
| EDIT | EDITAS MEDICINE INC | $56,652,000 | -24.8% | 3,376,184 | 0.0% | 19.98% | -0.2% | |
| TTOO | T2 BIOSYSTEMS INC | $6,261,000 | -39.0% | 1,950,583 | 0.0% | 2.21% | -19.0% | |
| EBIO | Exit | ELEVEN BIOTHERAPEUTICS INC | $0 | – | -1,324,018 | -100.0% | -0.77% | – |
| SELB | Exit | SELECTA BIOSCIENCES INC | $0 | – | -826,862 | -100.0% | -3.15% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -965,369 | -100.0% | -14.98% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SERES THERAPEUTICS INC | 29 | Q3 2023 | 68.0% |
| DENALI THERAPEUTICS INC | 24 | Q3 2023 | 50.9% |
| SYROS PHARMACEUTICALS INC | 24 | Q2 2022 | 27.3% |
| MODERNA INC | 20 | Q3 2023 | 76.9% |
| EVELO BIOSCIENCES INC | 20 | Q1 2023 | 41.2% |
| RUBIUS THERAPEUTICS INC | 18 | Q4 2022 | 60.7% |
| Axcella Health Inc | 17 | Q2 2023 | 3.5% |
| KALEIDO BIOSCIENCES INC | 13 | Q1 2022 | 9.5% |
| Foghorn Therapeutics Inc | 12 | Q3 2023 | 6.5% |
| Sana Biotechnology Inc | 11 | Q3 2023 | 18.4% |
View Flagship Pioneering Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-09-15 |
| 4 | 2023-08-15 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-07-13 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-02-27 |
| 13F-HR | 2023-02-14 |
View Flagship Pioneering Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.